secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2026-01-21T23:59:59+00:00
Accession:  0001824293-26-000014
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio announces 1-for-28 reverse stock split effective Jan 23, 2026 to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Stockholders approved reverse split at January 15, 2026 special meeting.
- Outstanding shares to reduce from ~15,016,434 to ~536,301; authorized shares unchanged.
- Cash in lieu of fractional shares at closing price on Jan 23, 2026.
- Proportional adjustments to options, warrants, convertible securities and stock plans.
- Trading to begin on split-adjusted basis on Nasdaq under ticker 'GRI' on Jan 26, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429326000014/0001824293-26-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429326000014/val-20260121.htm
  HTML page:      https://secwatch.observer/filing/0001824293-26-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer